Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

2nd Annual Market & Patient Access In Latin America Conference, 14-15 August 2012, Brazil

Date: May-15-2012
Understanding and optimizing market access strategies to penetrate the exciting
and diverse South & Central America

This event will provide participants with both a broad overview and specific detail of the market access, pricing and reimbursement environments in key Latin American countries such as Brazil, Mexico, Argentina, Colombia, Venezuela, Chile, Panama and Costa Rica. A thorough understanding will be achieved by hearing the perspectives of payers, government officials and key opinion leaders from academia, as well as learning from the case-study experiences from pharma industry veterans who have successfully overcome challenges to launch innovative medicines in this exciting region.

Why attend?
Learn how to demonstrate product value to local HTA agencies, regulators and payers.
Hear multiple perspectives from all stakeholders such as the pharmaceutical and medical device industries, academia, HTAs, regulators and payers.
View the potential picture of market growth and market access in Latin America.
Understand different market approaches and barriers to market access from the industry perspective.
Understand the market's affordability and willingness to reimburse innovative, high-cost drugs.
Benchmark, network and co-operate with pharma & non-pharma decision makers.

Agenda request

To request the full agenda please follow this link.

For Booking Information contact:

Erika Vavrovicova

Tel: +421 232 660 382

Fax: +421 2 3301 0331

Email: erika@nextlevelpharma.com

https://www.nextlevelpharma.com/events/view/market_patient_access_in_latin_america

Conference Dates: 14-15 August 2012

Venue: Rio de Janeiro, Brazil
Courtesy: Medical News Today
Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.